Capital Advantage
LLY icon

Capital Advantage’s Eli Lilly LLY Stock Holding History

Capital Advantage’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$671K Buy
580
+23
+4% +$27.1K 0.08% 88
2026
Q2 		$668K Buy
557
+24
+5% +$24.5K 0.08% 86
2026
Q1 		$490K Buy
533
+27
+5% +$27.4K 0.06% 98
2025
Q4 		$544K Sell
506
-94
-16% -$89.9K 0.07% 93
2025
Q3 		$458K Hold
600
– – 0.07% 100
2025
Q2 		$468K Buy
600
+29
+5% +$22.5K 0.07% 100
2025
Q1 		$441K Hold
571
– – 0.08% 92
2024
Q4 		$441K Buy
+571
New +$473K 0.08% 92

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $104B AUM 51.65% 1-Year Est. Return
Sapient Capital
Sapient Capital Indianapolis, Indiana $7.44B AUM 23.27% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return
Old National Bancorp
Old National Bancorp Evansville, Indiana $5.07B AUM 22.07% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
Goelzer Investment Management
Goelzer Investment Management Carmel, Indiana $2.28B AUM 31.27% 1-Year Est. Return
AMF Tjänstepension
AMF Tjänstepension Stockholm, Sweden $17.2B AUM 28.3% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $33.8B AUM 31.08% 1-Year Est. Return

Capital Advantage's LLY Position: Q3 2026 in Review

Capital Advantage increased its Eli Lilly (LLY) stake by 4.1% in Q3 2026, buying an estimated $27.1K and bringing the position to 580 shares worth $671K. The position accounts for 0.08% of the portfolio, ranked #88.

Capital Advantage first reported a position in LLY in Q4 2024 and has held it in 8 quarters since. 1,633 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Capital Advantage held 580 shares of Eli Lilly worth $671K as of Q3 2026.
  • Capital Advantage bought 23 Eli Lilly shares in Q3 2026, an estimated $27.1K.
  • Eli Lilly made up 0.08% of Capital Advantage's portfolio in Q3 2026, its #88 holding.
  • Capital Advantage first reported a position in Eli Lilly in Q4 2024 and has held it in 8 quarters since.
  • 1,633 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Capital Advantage's 13F filing for Q3 2026, filed 14 Oct 2026.